PROSTATE CARCINOMA METASTATIC IN THE BONE
Clinical trials for PROSTATE CARCINOMA METASTATIC IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CARCINOMA METASTATIC IN THE BONE trials appear
Sign up with your email to follow new studies for PROSTATE CARCINOMA METASTATIC IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Drug attack shows promise for tough prostate cancer
Disease control OngoingThis phase 2 trial tests whether adding the chemotherapy cabazitaxel to standard hormone therapy (abiraterone) can better control advanced prostate cancer that has spread and stopped responding to initial treatment. The study involves 223 men whose cancer progressed after docetax…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy targets bone metastases in prostate cancer
Disease control OngoingThis phase 2 trial studies whether adding radium-223 to enzalutamide works better than enzalutamide alone in men with castration-resistant prostate cancer that has spread to bones. Enzalutamide blocks male hormones that fuel cancer growth, while radium-223 delivers targeted radia…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cocktail of cancer drugs tested in advanced tumors
Disease control OngoingThis study tests the safety and effectiveness of combining the immunotherapy drug avelumab with other treatments (utomilumab, ivuxolimab, or radiation) in 173 people with advanced cancers that have not responded to standard therapies. The goal is to find tolerable doses and see i…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heat and radiation team up to fight spine cancer
Disease control OngoingThis study tests whether combining two treatments—thermal ablation (using heat to destroy tumor cells) and stereotactic radiosurgery (precise, high-dose radiation)—can better control cancer that has spread to the spine and is pressing on the spinal cord. About 60 adults with vari…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New cocktail aims to tame metastatic prostate cancer
Disease control OngoingThis phase 2 trial tests a combination of abiraterone, prednisone, and apalutamide in 60 men with hormone-naïve metastatic prostate cancer. The goal is to see how long patients can stay on treatment and how well it controls the cancer. All three drugs work by lowering or blocking…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immunotherapy-Chemo combo targets tough neuroendocrine cancers
Disease control OngoingThis early-phase trial tests whether adding the immunotherapy drug pembrolizumab to standard platinum-based chemotherapy can help people with rare, aggressive small cell or neuroendocrine cancers of the bladder or prostate. The study includes 15 participants whose cancer has spre…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC